Quanterix Corporation (NASDAQ: QTRX) announced that Anthem Blue Cross and Blue Shield will begin covering blood-based biomarker testing for Alzheimer's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE